| 11/05/2026 12:19 PM | FMR LLC (315066) Filed by LENZ Therapeutics (1815776) Subject | Form SCHEDULE 13G/A | |
| 11/03/2026 6:26 PM | Chevallard Daniel R. (1706176) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 3:08 PM | LENZ Therapeutics (1815776) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/02/2026 4:44 PM | Kolchinsky Peter (1384859) Reporting LENZ Therapeutics (1815776) Issuer RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 4:45 PM | LENZ Therapeutics (1815776) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13D/A | |
| 10/28/2026 3:34 PM | LENZ Therapeutics (1815776) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/27/2026 3:09 PM | BlackRock Portfolio Management LLC (2052113) Filed by LENZ Therapeutics (1815776) Subject | Form SCHEDULE 13G | |
| 10/21/2026 4:44 PM | LENZ Therapeutics (1815776) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 09/08/2026 8:59 AM | FMR LLC (315066) Filed by LENZ Therapeutics (1815776) Subject | Form SCHEDULE 13G/A | |
| 07/02/2026 4:00 PM | LENZ Therapeutics (1815776) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2026 3:53 PM | LENZ Therapeutics (1815776) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for LENZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/15/2026 7:22 PM | Kolchinsky Peter (1384859) Reporting LENZ Therapeutics (1815776) Issuer RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:17 PM | LENZ Therapeutics (1815776) Issuer Scheiner Zachary (1816523) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:18 PM | Guerard Frederic (1825009) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:18 PM | LENZ Therapeutics (1815776) Issuer Thunen Shelley B (1297491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:18 PM | LENZ Therapeutics (1815776) Issuer MCCOLLUM JAMES W (1200889) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:18 PM | Drapkin Kimberlee C (1340881) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:18 PM | George Jeffrey P. (1796789) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 3:39 PM | LENZ Therapeutics (1815776) Filer | Form DEF 14A | |
| 04/28/2026 3:42 PM | LENZ Therapeutics (1815776) Filer | Form DEFA14A | |
| 04/28/2026 3:44 PM | LENZ Therapeutics (1815776) Filer | Form ARS | |
| 04/08/2026 2:07 PM | LENZ Therapeutics (1815776) Subject Squarepoint Ops LLC (1642575) Filed by | Form SCHEDULE 13G | |
| 03/30/2026 7:46 AM | Chevallard Daniel R. (1706176) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 7:46 AM | LENZ Therapeutics (1815776) Issuer Schimmelpennink Evert B. (1713795) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 7:47 AM | George Jeffrey P. (1796789) Reporting LENZ Therapeutics (1815776) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 3:27 PM | LENZ Therapeutics (1815776) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/24/2026 3:10 PM | LENZ Therapeutics (1815776) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/24/2026 7:10 AM | LENZ Therapeutics (1815776) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 4:10 PM | LENZ Therapeutics (1815776) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:15 PM | LENZ Therapeutics (1815776) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/19/2025 6:02 PM | LENZ Therapeutics (1815776) Issuer Olsson Shawn (2015796) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:38 PM | LENZ Therapeutics (1815776) Subject Olsson Shawn (2015796) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |